Novel pathways and therapies in experimental diabetic atherosclerosis.
about
High Mobility Group Box-1: A Missing Link between Diabetes and Its ComplicationsThe association between postload plasma glucose levels and 38-year mortality risk of coronary heart disease: the prospective NHLBI Twin Study.Thrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic.Differences in cardiovascular risk factors and socioeconomic status do not explain the increased risk of death after a first stroke in diabetic patients: results from the Swedish Stroke Register.sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
P2860
Novel pathways and therapies in experimental diabetic atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel pathways and therapies in experimental diabetic atherosclerosis.
@en
Novel pathways and therapies in experimental diabetic atherosclerosis.
@nl
type
label
Novel pathways and therapies in experimental diabetic atherosclerosis.
@en
Novel pathways and therapies in experimental diabetic atherosclerosis.
@nl
prefLabel
Novel pathways and therapies in experimental diabetic atherosclerosis.
@en
Novel pathways and therapies in experimental diabetic atherosclerosis.
@nl
P2093
P2860
P356
P1476
Novel pathways and therapies in experimental diabetic atherosclerosis.
@en
P2093
Christine Koulis
Judy B de Haan
Terri J Allen
P2860
P304
P356
10.1586/ERC.12.13
P577
2012-03-01T00:00:00Z